{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-104218","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.532926+00:00","generated_at":"2026-05-15T12:53:56.031051+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"confidence":"high","headline":"Plus Therapeutics FY2025 net loss $22.4M; cash $13.1M, outlines 2026 milestones for REYOBIQ and CNSide","bullets":["Net loss $22.4M ($0.29/shr) vs $13.0M ($1.95/shr) in 2024; operating loss $15.3M vs $14.7M.","Cash and investments $13.1M at Dec 31, 2025 (up from $3.6M); raised $15M gross in upsized public offering.","CNSide lab licensed in 49 states; coverage agreements with Humana and UnitedHealthcare reach ~67M lives.","2026 milestones: REYOBIQ Phase 2 LM data Q3 2026, GBM data Q4; CNSide target >1,250 annual test orders, breakeven by 2027.","Secured AMA Category III CPT code for convection-enhanced delivery with REYOBIQ, unlocking market access."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-104218","json":"https://secwatch.observer/filing/0001193125-26-104218.json","markdown":"https://secwatch.observer/filing/0001193125-26-104218.md","text":"https://secwatch.observer/filing/0001193125-26-104218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526104218/0001193125-26-104218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526104218/pstv-20260312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:53:56.031051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}